Drugs / Vital Blue Dye
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02589366 | Nov 2015 → Apr 2018 | endometrial cancer | University of California, San Diego | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02509598 Background | Aug 2015 → Mar 2019 | melanoma, rhabdomyosarcoma | Cardinal Health 414, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vital Blue Dye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02589366 ↗ |
| Modality | Diagnostic / imaging agent | “Vital Blue Dye (tracing agent)” NCT02589366 ↗ |